Market Overview

Jim Cramer Gives His Opinion On NeoGenomics, Yeti And More

Share:

On CNBC's "Mad Money Lightning Round," Jim Cramer said that NeoGenomics, Inc. (NASDAQ: NEO) is a good spec, because early diagnostic of cancer is a holy grail.

Cramer is not a buyer of Yeti Holdings Inc (NYSE: YETI) because it's already up 100% for the year.

Nutanix Inc (NASDAQ: NTNX) is making a little comeback, but Cramer finds it too hard to recommend the stock.

Cadence Design Systems Inc (NASDAQ: CDNS) is overvalued, said Cramer. He added that the company has never been able to put together a systematic year of great numbers. He is not a buyer.

Posted-In: CNBC Jim Cramer Mad Money mad money Lightning RoundMedia

 

Related Articles (CDNS + NEO)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo

Mike Khouw's Lululemon Trade

These Companies Have Some Of The Toughest Job Interviews